Human Cell,
Journal Year:
2023,
Volume and Issue:
36(4), P. 1265 - 1282
Published: April 28, 2023
Abstract
Metabolic
and
inflammatory
pathways
are
highly
interdependent,
both
systems
dysregulated
in
Type
2
diabetes
(T2D).
T2D
is
associated
with
pre-activated
signaling
networks,
aberrant
cytokine
production
increased
acute
phase
reactants
which
leads
to
a
pro-inflammatory
‘feed
forward
loop’.
Nutrient
‘excess’
conditions
hyperglycemia,
elevated
lipids
branched-chain
amino
acids
significantly
alter
the
functions
of
immune
cells
including
neutrophils.
Neutrophils
metabolically
active
utilizes
energy
from
glycolysis,
stored
glycogen
β
-oxidation
while
depending
on
pentose
phosphate
pathway
for
NADPH
performing
effector
such
as
chemotaxis,
phagocytosis
forming
extracellular
traps.
changes
result
constitutive
activation
impeded
acquisition
or
regulatory
activities
neutrophils
render
subjects
recurrent
infections.
Increased
flux
through
polyol
hexosamine
pathways,
advanced
glycation
end
products
(AGEs),
protein
kinase
C
isoforms
lead
(a)
an
enhancement
superoxide
generation;
(b)
stimulation
subsequently
(c)
abnormal
host
responses.
Neutrophil
dysfunction
diminishes
effectiveness
wound
healing,
successful
tissue
regeneration
surveillance
against
offending
pathogens.
Hence,
reprogramming
determines
frequency,
severity
duration
infections
T2D.
The
present
review
discusses
influence
altered
immuno-metabolic
axis
neutrophil
along
challenges
therapeutic
opportunities
clinical
management
T2D-associated
Neurology,
Journal Year:
2020,
Volume and Issue:
95(8)
Published: June 2, 2020
The
coronavirus
disease
2019
(COVID-19)
has
spread
worldwide
since
December
2019.
Neurologic
symptoms
have
been
reported
as
part
of
the
clinical
spectrum
disease.
We
aimed
to
determine
whether
neurologic
manifestations
are
common
in
hospitalized
patients
with
COVID-19
and
describe
their
main
characteristics.We
systematically
reviewed
all
diagnosed
admitted
hospital
a
Spanish
population
during
March
2020.
Demographic
characteristics,
systemic
manifestations,
complementary
tests
were
analyzed.Of
841
(mean
age
66.4
years,
56.2%
men),
57.4%
developed
some
form
symptom.
Nonspecific
such
myalgias
(17.2%),
headache
(14.1%),
dizziness
(6.1%)
present
mostly
early
stages
infection.
Anosmia
(4.9%)
dysgeusia
(6.2%)
tended
occur
(60%
first
manifestation)
more
frequent
less
severe
cases.
Disorders
consciousness
occurred
commonly
(19.6%),
older
advanced
stages.
Myopathy
(3.1%),
dysautonomia
(2.5%),
cerebrovascular
diseases
(1.7%),
seizures
(0.7%),
movement
disorders
encephalitis
(n
=
1),
Guillain-Barré
syndrome
optic
neuritis
1)
also
reported,
but
frequent.
complications
cause
death
4.1%
deceased
study
participants.Neurologic
COVID-19.
In
our
series,
than
half
presented
Clinicians
need
maintain
close
surveillance
for
prompt
recognition
these
complications.
mechanisms
consequences
acute
respiratory
type
2
involvement
require
further
studies.
Diabetes/Metabolism Research and Reviews,
Journal Year:
2020,
Volume and Issue:
37(2)
Published: June 27, 2020
The
outbreak
of
the
coronavirus
disease
2019
(Covid-19)
has
become
an
evolving
worldwide
health
crisis.
With
rising
prevalence
obesity
and
diabetes
come
increasing
awareness
their
impacts
on
infectious
diseases,
including
increased
risk
for
various
infections,
post-infection
complications
mortality
from
critical
infections.
Although
epidemiological
clinical
characteristics
Covid-19
have
been
constantly
reported,
no
article
systematically
illustrated
role
in
Covid-19,
or
how
affects
diabetes,
special
treatment
these
at-risk
populations.
Here,
we
present
a
synthesis
recent
advances
our
understanding
relationships
between
obesity,
along
with
underlying
mechanisms,
provide
guidance
International Journal of Obesity,
Journal Year:
2020,
Volume and Issue:
44(8), P. 1790 - 1792
Published: May 14, 2020
Coronavirus
disease
2019
(COVID-19)
and
the
risk
of
severe
acute
respiratory
syndrome
coronavirus
2
(SARS-CoV-2)
poses
a
particular
to
people
living
with
preexisting
conditions
that
impair
immune
response
or
amplify
pro-inflammatory
response.
Low-grade
chronic
systemic
inflammation,
common
in
obesity,
is
associated
development
atherosclerosis,
type
diabetes,
hypertension,
well
known
comorbidities
adversely
affect
outcomes
patients
COVID-19.
Risk
stratification
based
on
Edmonton
Obesity
Staging
System
(EOSS),
which
classifies
obesity
presence
medical,
mental,
and/or
functional
complications
rather
than
body
mass
index
(BMI),
has
been
shown
be
better
predictor
all-cause
mortality
it
may
EOSS
stages
describe
hyperinflammation
COVID-19
infection.
Analyzing
group
metabolic
ill
(EOSS
3),
we
found
an
increased
interleukin-6
linear
regression
analysis
showed
positive
correlation
C-reactive
protein
(CRP)
(p
=
0.014)
waist-to-hip-ratio
(WHR)
0.031).
Physicians
should
aware
these
findings
Early
identification
possible
could
fundamental
guide
decision
making
regarding
hospitalization,
early
support,
therapy
immunosuppression
improve
mortality.
Clinical Obesity,
Journal Year:
2020,
Volume and Issue:
10(6)
Published: Aug. 28, 2020
Summary
Obesity
is
an
emerging
independent
risk
factor
for
susceptibility
to
and
severity
of
coronavirus
disease
2019
(COVID‐19)
caused
by
the
severe
acute
respiratory
syndrome
coronavirus‐2
(SARS‐CoV‐2).
Previous
viral
pandemics
have
shown
that
obesity,
particularly
obesity
(BMI
>
40
kg/m
2
),
associated
with
increased
hospitalization,
critical
care
admission
fatalities.
In
this
narrative
review,
we
examine
evidence
influence
on
COVID‐19,
challenges
clinical
management
from
pulmonary,
endocrine
immune
dysfunctions
in
individuals
identify
potential
areas
further
research.
We
recommend
people
be
deemed
a
vulnerable
group
COVID‐19;
trials
pharmacotherapeutics,
immunotherapies
vaccination
should
prioritize
inclusion
obesity.
AJP Endocrinology and Metabolism,
Journal Year:
2020,
Volume and Issue:
319(1), P. E105 - E109
Published: May 27, 2020
Recent
reports
have
shown
a
strong
association
between
obesity
and
the
severity
of
COVID-19
infection,
even
in
absence
other
comorbidities.
After
infecting
host
cells,
severe
acute
respiratory
syndrome
coronavirus
2
(SARS-CoV-2)
may
cause
hyperinflammatory
reaction
through
excessive
release
cytokines,
condition
known
as
"cytokine
storm,"
while
inducing
lymphopenia
disrupted
immune
response.
Obesity
is
associated
with
chronic
low-grade
inflammation
dysregulation,
but
exact
mechanisms
which
it
exacerbates
infection
are
not
fully
clarified.
The
production
increased
amounts
cytokines
such
TNFα,
IL-1,
IL-6,
monocyte
chemoattractant
protein
(MCP-1)
lead
to
oxidative
stress
defective
function
innate
adaptive
immunity,
whereas
activation
NOD-like
receptor
family
pyrin
domain
containing
3
(NLRP3)
inflammasome
seems
play
crucial
role
pathogenesis
infection.
Endothelial
dysfunction
arterial
stiffness
could
favor
recently
discovered
endothelium
by
SARS-CoV-2,
alterations
cardiac
structure
prothrombotic
microenvironment
provide
link
for
cardiovascular
events
these
patients.
successful
use
anti-inflammatory
agents
IL-1
IL-6
blockers
similar
settings,
like
that
rheumatoid
arthritis,
has
triggered
discussion
whether
be
administrated
selected
patients
disease.
Nano Letters,
Journal Year:
2023,
Volume and Issue:
23(14), P. 6610 - 6618
Published: July 17, 2023
Diabetic
ulcers
have
received
much
attention
in
recent
years
due
to
their
high
incidence
and
mortality,
motivating
the
scientific
community
develop
various
strategies
for
such
chronic
disease
treatments.
However,
therapeutic
outcome
of
these
approaches
is
highly
compromised
by
invasive
bacteria
a
severe
inflammatory
microenvironment.
To
overcome
dilemmas,
microenvironment-responsive
self-delivery
glucose
oxidase@manganese
sulfide
(GOx@MnS)
nanoparticles
(NPs)
are
developed
one-step
biomineralization.
When
they
encounter
level
ulcer
site,
GOx
particles
catalyze
decrease
local
pH
trigger
steady
release
both
manganese
ions
(Mn2+)
hydrogen
(H2S).
Mn2+
reacts
with
peroxide
generate
hydroxyl
radicals
elimination
bacterial
infection;
meanwhile,
H2S
able
suppress
response
accelerate
diabetic
wound
healing
through
macrophage
polarization.
The
excellent
biocompatibility,
strong
bactericidal
activity,
considerable
immunomodulatory
effect
promise
GOx@MnS
NPs
great
potential
treatment.